Diagnostic Technologies

AI-powered endoscope doubles detection of high-risk esophageal lesions

By Nick Paul Taylor

Deep learning has doubled the detection of high-risk lesions during routine endoscopies in a clinical trial of more than 3,000 patients in China.

April 17, 2024

Veracyte to share bundle of genomic classifier studies at AUA 2024

By LabPulse.com staff writers

Veracyte has announced that the American Urological Association's May meeting will feature nine sessions related to evaluations of its prostate cancer and bladder cancer genomic tests.

April 16, 2024

Roche's breast cancer CDx receives CE Mark

By LabPulse.com staff writers

Roche has received the CE Mark for the first companion diagnostic (CDx) test to identify patients with HER2-low metastatic breast cancer who may be eligible for treatment with Enhertu.

April 10, 2024

Labcorp expands precision oncology offerings

By Matt Limb

Laboratory services firm Labcorp has announced the expansion of its precision oncology portfolio, aimed at supporting clinical research and advancing drug development programs.

April 12, 2024

Urine test halves use of invasive procedure to monitor bladder cancer

By Nick Paul Taylor

A urine test can cut the number of cystoscopies necessary to follow up high-risk bladder cancer patients without increasing the risk of recurrence, a study has found.

April 11, 2024

Researchers tweak TB treatment assay to support global use

By Nick Paul Taylor

Researchers have developed a tuberculosis (TB) treatment assay that could be a faster, simpler method for monitoring patients.

April 10, 2024

Solvd Health CEO responds to harsh letter addressing FDA, CMS

By Liz Carey

Solvd Health CEO Dr. Keri Donaldson responded to critics of his company's machine learning classifier clinical laboratory test that uses genotyping to aid healthcare providers in OUD assessments in adults prior to first-time opioid prescriptions.

April 9, 2024

Researchers design AI model to generate new antibiotics

By LabPulse.com staff writers

Researchers have devised an artificial intelligence (AI) model to develop potential new antibiotics which chemists can synthesize in the lab.

April 9, 2024

Quest and Broad partner for infant whole genome sequencing research

By LabPulse.com staff writers

Quest Diagnostics and Broad Clinical Labs have announced a research collaboration exploring whole genome sequencing (WGS) on infants as a first-line genetic test for diagnosis of developmental delay disorders.

April 3, 2024

FDA clears another blood-based TBI POC test

By LabPulse.com staff writers

Abbott furthers its point-of-care (POC) assay for measuring traumatic brain injury biomarkers from whole blood.

April 1, 2024

Researchers map protein biomarkers in sepsis fight

By Liz Carey

Swedish researchers are mapping patterns of protein biomarkers in sepsis that could be useful for simple blood tests in the emergency department, according to research to be presented at ECCMID 2024.

April 2, 2024

Molecular diagnostic test study continues EET benefit assessment

By Liz Carey

A molecular oncology gene expression profiling (GEP) test for breast cancer biomarkers may influence extended endocrine therapy (EET) treatment decisions, according to an impact study.

April 2, 2024

Page 1 of 310

Next Page